CTSI Director’s Invention Going to Clinical Trial

CTSI Director’s Invention Going to Clinical Trial

Reza Shaker, MD
© Mark Derse 2012

Reza Shaker, MD, Joseph E. Geenen Professor and Chief, Division of Gastroenterology and Hepatology, Senior Associate Dean for Clinical and Translational Research at MCW and CTSI Director has developed a device that is designed to minimize or eliminate symptoms of extraesophageal acid reflux disease (EERD) without surgical intervention. The Reza Band™, UES Assist Device is a band that is worn around the neck and prevents stomach acid from traveling into the throat, vocal cords, windpipe and lungs by applying pressure to the upper esophageal sphincter.

The Reza Band™ has already helped 28 research participants in two preliminary studies at MCW and is scheduled to be in clinical trials across the U.S. in the fall.

The Medical College of Wisconsin recently entered into a licensing agreement with Somna Therapeutics, LLC for further development and marketing of the Reza Band™.

CTSI would like to thank the MCW Office of Technology Development for their great support in advancing scientific discoveries and assisting our investigators manage their discoveries, inventions and other intellectual property.

Clinical and Translational Science Institute
taylors@taylor-and-taylor.com


NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.

PARTNERS

Zablocki VA Medical CenterMedical College of WisconsinMSOE